Algernon Pharmaceuticals (XCNQ:AGN) Debt-to-Revenue : N/A (As of Nov. 2023)

Algernon Pharmaceuticals Debt-to-Revenue Chart

Algernon Pharmaceuticals Annual Data
	Trend	Aug15	Aug16	Aug17	Aug18	Aug19	Aug20	Aug21	Aug22	Aug23
Debt-to-Revenue		Get a 7-Day Free Trial				N/A	N/A	N/A	N/A	N/A

Algernon Pharmaceuticals Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Debt-to-Revenue	Get a 7-Day Free Trial															N/A	N/A	N/A	N/A	N/A

Competitive Comparison of Algernon Pharmaceuticals's Debt-to-Revenue

For the Biotechnology subindustry, Algernon Pharmaceuticals's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Algernon Pharmaceuticals's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Algernon Pharmaceuticals's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Algernon Pharmaceuticals's Debt-to-Revenue falls into.

Algernon Pharmaceuticals Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Algernon Pharmaceuticals's Debt-to-Revenue for the fiscal year that ended in Aug. 2023 is calculated as

Algernon Pharmaceuticals's annualized Debt-to-Revenue for the quarter that ended in Nov. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Nov. 2023) Revenue data.

Algernon Pharmaceuticals Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Algernon Pharmaceuticals's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Algernon Pharmaceuticals (XCNQ:AGN) Business Description